Skip to content

Clinical trials

Phase 3 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 3 Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20042
20051
20062
20072
20086
20092
20103
20112
20122
20131
20146
20153
20181
20194
20202
20216
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated11
Active, not recruiting7
Unknown status4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Celgene4
AOP Orphan Pharmaceuticals AG3
Children's Oncology Group3
Fred Hutchinson Cancer Center3
Incyte Corporation3
Novartis Pharmaceuticals3
Ariad Pharmaceuticals2
CTI BioPharma2
Case Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders62
Primary Myelofibrosis29
Myelodysplastic Syndromes26
Leukemia24
Leukemia, Myeloid, Acute22
Leukemia, Myelomonocytic, Chronic22
Precursor Cell Lymphoblastic Leukemia-Lymphoma21
Leukemia, Lymphocytic, Chronic, B-Cell20
Multiple Myeloma20
Lymphoma, Non-Hodgkin19

Trials

Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.